东莞市宇瞳光学科技股份有限公司 2023 年度董事会工作报告 2023 年度，公司董事会严格按照《中华人民共和国公司法》（以下简称《公 司法》）、《中华人民共和国证券法》（以下简称《证券法》）等法律法规和《公 司章程》等相关规定，认真履行职责，贯彻执行股东大会、董事会的各项决议， 恪尽职守、勤勉尽责，积极推动公司各项业务的发展和规范公司治理，切实维护 公司和股东尤其是中小股东的合法权益。现将 2023 年度董事会工作汇报如下： 一、 2023 年度公司经营情况 公司是以光学产品为核心，集研发、生产、营销与售后服务为一体的专业 光学解决方案提供商，产品主要应用于安防监控、智能驾驶、机器视觉及视频 会议、智能家居、直播系统、3C 数码、民用测温成像等高精密光学系统。 （三） 独立董事履职情况 报告期内，公司董事会充分发挥董事会在公司治理体系中的作用，共组织召 开九次董事会会议，会议的召集与召开程序、出席会议人员的资格、会议表决程 序和决议内容均符合《公司法》、《公司章程》和《董事会议事规则》的有关规 定。具体情况如下： | 序号 | 会议日期 | 会议名称 | 审议事项 | | | | | | | | | --- ...

东莞市宇瞳光学科技股份有限公司 2023 年度监事会工作报告 2023 年度，东莞市宇瞳光学科技股份有限公司（以下简称"公司"）监事会严格 按照《中华人民共和国公司法》（以下简称"《公司法》"） 、《中华人民共和国证 券法》（以下简称"《证券法》"）等有关法律、法规及《东莞市宇瞳光学科技股份有 限公司章程》（以下简称"《公司章程》"）、《监事会议事规则》的要求，以维护公 司利益和股东利益为原则，认真履行和独立行使监事会的监督职权和职责，列席公司董 事会会议及股东大会、审议公司定期报告、督促公司董事会及经营层执行股东大会决议 的情况、检查董事、高管人员履职情况等，对公司依法运作情况、经营活动、财务状况、 重大决策以及董事、高级人员履职情况等方面实施了有效监督，较好地保障了公司股东 权益、公司利益和员工的合法权益，进一步促进了公司的规范化运作。现将监事会 2023 年的主要工作报告如下： 一、监事会召开会议情况 报告期内，公司监事会共召开九次会议，具体情况如下： | 序号 | | 召开时间 | | 会议届次 | 审议通过的议案 | | --- | --- | --- | --- | --- | --- | | 1 ...

东莞市宇瞳光学科技股份有限公司董事会 董事会关于独立董事独立性情况的专项意见 根据《上市公司独立董事管理办法》、《上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等要求，结合独立董事出具的《独立董事独立性自查情况表》，经 核查，公司董事会认为：认为公司独立董事不存在任何妨碍其进行独立客观判断的关系， 不存在影响独立董事独立性的情况，符合《上市公司独立董事管理办法》《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规及《公司 章程》中关于独立董事的任职资格及独立性的要求。 东莞市宇瞳光学科技股份有限公司 2024 年 4 月 24 日 ...

Financial Performance - The company's revenue for Q1 2024 reached ¥568,652,493.05, representing a 38.47% increase compared to ¥410,671,618.86 in the same period last year[6] - Net profit attributable to shareholders surged by 294.04% to ¥40,261,642.91 from ¥10,217,773.62 year-on-year[6] - The basic earnings per share increased to ¥0.13, a 333.33% rise from ¥0.03 in the previous year[6] - Total operating revenue for Q1 2024 reached ¥568,652,493.05, a significant increase of 38.4% compared to ¥410,671,618.86 in the same period last year[21] - The company's net profit margin improved, with net profit for the period increasing to ¥28,636,407.91 from ¥19,846,435.83, representing a growth of 44.2%[21] - The net profit for Q1 2024 was CNY 46,665,562.16, a significant increase from CNY 9,627,874.12 in Q1 2023, representing a growth of approximately 385%[22] - The total comprehensive income for Q1 2024 was CNY 46,959,414.49, compared to CNY 9,589,490.49 in Q1 2023, marking an increase of approximately 389%[23] Cash Flow and Assets - Operating cash flow net amount decreased by 17.57% to ¥98,407,982.90 from ¥119,381,414.02[6] - Cash and cash equivalents at the end of the period increased to ¥541,732,799.45 from ¥504,286,401.18, marking a rise of 7.4%[18] - Cash flow from operating activities was CNY 98,407,982.90, down from CNY 119,381,414.02 in the same period last year, a decrease of approximately 17.5%[24] - The company reported a cash and cash equivalents balance of CNY 482,625,880.32 at the end of Q1 2024, an increase from CNY 342,604,428.76 at the end of Q1 2023, representing a growth of about 40.9%[25] - The company incurred a net cash outflow from investing activities of CNY 61,172,516.22, an improvement from a net outflow of CNY 110,286,070.21 in the previous year[25] Costs and Expenses - The company experienced a 36.49% increase in operating costs, totaling ¥448,655,639.16, primarily due to increased sales volume[10] - Total operating costs for Q1 2024 were ¥540,016,085.14, up from ¥408,825,183.03, reflecting a year-over-year increase of 32.1%[21] - The company reported a significant increase in R&D expenses, which rose to ¥24,449,444.59 from ¥22,980,413.54, an increase of 6.4%[21] - The company’s income tax expense rose by 390.54% to ¥3,529,656.38, reflecting the increase in profits[10] - The company reported a tax expense of CNY 3,529,656.38 for Q1 2024, compared to CNY 719,548.43 in Q1 2023, indicating an increase of approximately 389%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,297, with no preferred shareholders[13] - The company repurchased a total of 2,429,000 shares at a total cost of 21,090,165 RMB as of March 31, 2024[16] - The total number of restricted shares increased to 89,137,592 shares, with 2,700,000 shares released from restriction during the period[15] - The company has a commitment to release restricted shares annually at a rate of 25% of the total shares held by executives[15] - The company’s board approved a share repurchase plan to maintain company value and protect shareholder interests[16] - The total number of shares held by the top 10 shareholders remains stable, reflecting consistent ownership structure[14] Investments and Acquisitions - Cash outflow for acquiring subsidiaries was ¥43,067,825.45, indicating ongoing expansion through acquisitions[11] - The company reported a 2267.81% increase in investment income to ¥373,314.48, resulting from returns on bank wealth management products[10] - Cash received from investment redemption amounted to ¥100,000,000.00, marking a significant inflow from financial product redemptions[11] - Cash received from investment income increased dramatically by 232060.75% to ¥373,314.48, driven by higher returns from bank financial products[11] Financial Strategy and Governance - The company’s financial strategy includes using its own funds for share repurchase to enhance shareholder value[16] - The company’s governance meetings were held to discuss and approve key financial strategies, including share repurchase[16] - The company is committed to adhering to regulations regarding the release of restricted shares as per its equity incentive commitments[15] - The company’s executive shareholding structure includes various lock-up periods and release schedules[15]

东莞市宇瞳光学科技股份有限公司 | 证券代码：300790 | 证券简称：宇瞳光学 | 公告编号：2024-047 | | --- | --- | --- | | 债券代码：123219 | 债券简称：宇瞳转债 | | 关于公司2023年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 东莞市宇瞳光学科技股份有限公司(以下简称"公司")于 2024 年 4 月 24 日召开 第三届董事会第二十二次会议及第三届监事会第二十次会议，审议通过了《关于公司 2023 年度利润分配预案的议案》，现在将相关情况公告如下： 一、2023 年度利润分配预案基本情况 根据华兴会计师事务所（特殊普通合伙）出具的公司《2023 年度审计报告》，公司 2023 年度实现归属于母公司所有者的净利润为 30,854,897.28 元，母公司实现净利润 51,819,664.39 元，截止 2023 年 12 月 31 日，母公司累计未分配利润为 580,771,446.34 元，合并报表未分配利润为 646,853,458.07 元，母公司累计资本公积为 872,64 ...

东莞市宇瞳光学科技股份有限公司 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性， 并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控 制进行监督。经理层负责组织领导企业内部控制的日常运行。公司董事会、监事会及董 事、监事、高级管理人员保证本报告内容不存在任何虚假记载、误导性陈述或重大遗漏， 并对报告内容的真实性、准确性和完整性承担个别及连带法律责任。 2023年度内部控制自我评价报告 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信 息真实完整，提高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限 性，故仅能为实现上述目标提供合理保证。此外，由于情况的变化可能导致内部控制变 得不恰当，或对控制政策和程序遵循的程度降低，根据内部控制评价结果推测未来内部 控制的有效性具有一定的风险。 东莞市宇瞳光学科技股份有限公司全体股东： 二、内部控制评价结论 根据公司财务报告内部控制重大缺陷的认定情况，于内部控制评价报告基准日，不 存在财务报告内部控制重大缺陷。董事会认为，公司已按照企业内部控制规范体系和相 关规定的要求在所 ...

| 证券代码：300790 | 证券简称：宇瞳光学 | 公告编号：2024-050 | | --- | --- | --- | | 债券代码：123219 | 债券简称：宇瞳转债 | | 东莞市宇瞳光学科技股份有限公司 关于回购注销2020年限制性股票激励计划部分限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 东莞市宇瞳光学科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召开 第三届董事会第二十二次会议、第三届监事会第二十次会议，审议通过《关于回购注销 2020 年限制性股票激励计划部分限制性股票的议案》，根据《上市公司股权激励管理办 法》《2020 年限制性股票激励计划（草案）》（以下简称"《2020 年激励计划》"） 等相关规定，鉴于 2020 年限制性股票激励计划授予的 32 名激励对象离职而不再符合激 励对象条件，及另外115名授予的激励对象第三个解除限售期公司业绩未达到考核要求， 公司决定将激励对象所持有的已获授但尚未解锁的2,384,760股限制性股票予以回购注 销，占公司目前总股本的 0.7107%。本议案 ...

| 证券代码：300790 | 证券简称：宇瞳光学 | 公告编号：2024-049 | | --- | --- | --- | | 债券代码：123219 | 债券简称：宇瞳转债 | | 东莞市宇瞳光学科技股份有限公司 东莞市宇瞳光学科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召 开第三届董事会第二十二次会议及第三届监事会第二十次会议，审议通过了《关于 2024 年度向银行等金融机构申请授信额度及相应担保事项的议案》，本议案尚需提 交股东大会审议，现将有关事项公告如下： 一、申请授信额度情况概述 为了满足公司发展需要及经营资金需求，2024 年度公司及全资子公司上饶市宇 瞳光学有限公司（以下简称"上饶宇瞳"）、东莞市宇瞳汽车视觉有限公司（以下简 称"宇瞳汽车视觉"）、东莞市宇承科技有限公司（以下简称"宇承科技"）拟向银 行等金融机构申请总额不超过 30.20 亿元人民币的综合融资授信额度（最终以各金融 机构实际核准的授信额度为准），并可互相提供担保，在此额度内由公司及子公司根 据实际资金需求进行授信申请。 上述综合融资授信额度，主要用于银行贷款、银行承兑汇票、信用证、保函、票 据质押 ...

Financial Performance - Total revenue for 2023 reached CNY 2,145,518,800.85, an increase of 16.21% compared to the previous year[3] - Net profit attributable to shareholders was CNY 30,801,123.43, a decrease of 78.63% year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 18,648,916.81, down 81.99% compared to the previous year[4] - Basic earnings per share decreased to CNY 0.09, a decline of 79.55% year-on-year[3] - The company's weighted average return on equity dropped to 1.63%, down from 8.41% in the previous year, a decline of 6.78 percentage points[3] Assets and Equity - The total assets as of December 31, 2023, amounted to CNY 5,055,995,210.90, reflecting an 18.27% increase from the previous year[4] - The company's equity attributable to shareholders increased by 4.49% to CNY 1,881,057,491.12[4] Challenges and Factors Affecting Performance - The decline in performance was attributed to increased competition in the security industry and a decrease in product prices and gross margins[4] - Financial expenses increased, along with provisions for goodwill impairment, impacting overall profitability[4] - Some subsidiaries are still in the ramp-up phase and have not yet started generating profits[4]

Financial Performance - The estimated net profit for Q1 2024 is projected to be between 35 million to 45 million CNY, representing an increase of 242.54% to 340.41% compared to the same period last year, which was 10.22 million CNY [4]. - The estimated net profit after deducting non-recurring gains and losses is projected to be between 31 million to 41 million CNY, reflecting an increase of 284.17% to 408.09% from last year's 8.07 million CNY [4]. - Non-recurring gains and losses are expected to impact net profit by an estimated amount between 4 million to 4.5 million CNY [5]. Business Strategy - The increase in performance is primarily attributed to active market expansion efforts, strengthening traditional business, and developing emerging sectors such as automotive and micro-single lenses [5]. - The company emphasizes that the performance forecast is based on preliminary calculations by the finance department and has not been audited [6].